repros therapeutics (RPRX)

- nasdaq
$17.19 April 24, 2014-04:00 PM ET
Chart_RPRX_365_13.jpg
Chart Type 1D 5D 1M 3M 6M 1Y 2Y 5Y

 

Prev Close: $17.51 Day's Range:

Open: 52wk Range: $13.93 - $29.79

P/E Ratio: 0 Volume:

Beta: -0.64 Avg Vol (3m): 253,995

Div & Yield: Market Cap(Mil.): 403

EPS (ttm): -1.33 P/E (ttm): -12.92


repros therapeutics News
  • Repros Receives FDA Guidance That It May Proceed To Conduct Phase 1 And 2 Studies Of Oral Proellex
    3/17/2014
  • Repros Therapeutics Announces Addl. Results From ZA-300 Six Month Study Of Androxal In Men With Secondary Hypogonadism
    2/10/2014
  • Repros Meets With FDA To Discuss Data Requirements For Androxal; NDA Submission Remains Anticipated By Year End 2014
    2/6/2014
  • Repros Therapeutics Appoints Michael Suesserman To Board Of Directors
    12/19/2013
  • Repros Therapeutics Says FDA Schedules Face To Face Meeting To Discuss Androxal Efficacy
    11/25/2013

Next 10 Headlines